Intrinsic Value
Protalix BioTherapeutics, Inc. (PLX)
$1.15
-0.03 (-2.54%)
| Enterprise Value | -285.77 |
|---|---|
| Net Debt | 2.65 |
| Equity Value | -288.42 |
| Shares Outstanding | 82.42 |
| Equity Value Per Share | -3.50 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt